Istisociclib

N/A

Report date: 2025/02/19 20:00:46
NME

Base Information

Drug NameIstisociclib
Drug Alias NameKB-0742KI-ARv-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKronos Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIgnota Labs LtdKronos Bio Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursOvarian NeoplasmsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A